Xyntha Kit
Product Images NDC 58394-024

Product Visual Gallery

This gallery contains 51 technical images submitted to the FDA as part of the official labeling for Xyntha (NDC 58394-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Xyntha 01)

An instructional illustration showing hands preparing a syringe for an injection by removing the cap or connecting the syringe to another device. The image demonstrates proper handling technique, indicated by arrows showing the direction of movement.*

FDA Label Image

Figure (Xyntha 02)

An instructional illustration showing a hand opening a vial by removing the cap, likely depicting a step in preparing the Xyntha antihemophilic factor (recombinant) kit for use.*

FDA Label Image

Figure (Xyntha 03)

An instructional illustration showing hands preparing a vial or kit component. One hand removes a protective covering from the vial, while the other hand positions a cap or connector to be placed onto the vial. The image appears to guide proper assembly or use of a medical or pharmaceutical kit.*

FDA Label Image

Figure (Xyntha 04)

An instructional illustration showing two hands holding syringes differently, likely demonstrating the correct or recommended technique for handling or preparing the syringe associated with the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Figure (Xyntha 05)

An instructional illustration showing a hand gripping a syringe with multiple adjustment positions indicated by arrows above the plunger, demonstrating how to turn or adjust the syringe plunger.*

FDA Label Image

Figure (Xyntha 06)

An instructional illustration showing two step-by-step hand positions for handling a syringe or vial, demonstrating proper technique for preparing or mixing medication within a syringe kit.*

FDA Label Image

Figure (Xyntha 07)

An instructional illustration showing hands preparing a medication kit. One hand removes a cap from a vial, while another hand fixes a needle onto an intravenous tube attached to a syringe. The diagram depicts assembly steps for intravenous administration of a drug.*

FDA Label Image

Figure (Xyntha 08)

An instructional illustration showing infusion of medication into a vein in the arm using a syringe and tubing. The diagram depicts a hand holding the syringe attached to an intravenous line inserted into a vein, suggesting a typical setup for intravenous drug administration.*

FDA Label Image

Figure (Xyntha 09)

An instructional illustration showing two hands preparing an injection. One hand holds a vial while the other hand inserts a syringe into the vial, indicating the process of drawing medication into the syringe.*

FDA Label Image

Figure (Xyntha 10)

An instructional illustration showing two hands each holding a syringe. The left syringe is being pulled upwards, indicated by an arrow pointing up, while the right syringe is held steady. The image likely demonstrates a step in syringe preparation or use related to the product Xyntha.*

FDA Label Image

Figure (Xyntha 11)

An instructional illustration showing two hands preparing a syringe with medication. One hand holds a vial steady while the other hand attaches or adjusts the syringe on top of the vial, demonstrating a step in medication preparation or reconstitution.*

FDA Label Image

Figure (Xyntha 12)

An instructional illustration showing two hands performing a preparation step for medication, where one hand holds a vial and the other hand is inserting a syringe needle into the vial with a downward arrow indicating the motion.*

FDA Label Image

Figure (Xyntha 13)

An instructional illustration showing hands using a syringe to extract or add liquid to a vial. The image depicts the proper alignment and motion needed to connect the syringe with the vial stopper, likely indicating a step in medication preparation.*

FDA Label Image

Figure (Xyntha 14)

An instructional black-and-white illustration showing two hands: one holding a vial and the other inserting a syringe into the vial. The image depicts the process of drawing liquid from the vial into the syringe, likely part of the preparation steps for a medication kit.*

FDA Label Image

Figure (Xyntha 15)

An instructional black-and-white line drawing showing hands assembling a syringe with an arrow indicating the direction to insert or connect a component. This diagram likely illustrates part of the preparation or administration process for the drug Xyntha, antihemophilic factor (recombinant), supplied as a kit by Wyeth BioPharma.*

FDA Label Image

Figure (Xyntha 16)

An instructional illustration showing two hands holding a syringe. The left hand is depicted pressing a plunger, indicated by an upward arrow, while the right hand holds the syringe steady, demonstrating proper syringe handling technique.*

FDA Label Image

Figure (Xyntha 17)

An instructional illustration showing hands manipulating a syringe and vial adapter, demonstrating steps to connect or prepare the injection device. The image depicts the process of twisting and attaching syringe components, likely for medication preparation.*

FDA Label Image

Figure (Xyntha 18)

An instructional illustration depicting two hands assembling or preparing a syringe, with one hand holding the syringe and the other attaching or removing a component, indicated by arrows showing the direction of movement.*

FDA Label Image

Figure (Xyntha 19)

An instructional illustration depicting the correct method to attach a needle to a syringe, showing hands holding the syringe and needle with directional arrows indicating rotation and insertion steps.*

FDA Label Image

Figure (Xyntha 20)

An instructional illustration showing a person holding a vial with one hand and removing or preparing to remove the cap with the other hand. This image likely demonstrates proper handling of the medication vial in the Xyntha kit.*

FDA Label Image

Logo (Xyntha 21)

Illustration showing hands removing the protective cap from a vial. The sequence demonstrates grasping and pulling off the cap as indicated by arrows, likely part of instructions for preparing the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Principal Display Panel (1000 IU Range Dual-Chamber Syringe Label)

An instructional illustration showing two views of a hand holding a syringe. The left side shows the syringe with an upward arrow, indicating a step in preparing or using the syringe, and the right side shows the syringe held in a thumb-and-finger grip.*

FDA Label Image

Principal Display Panel (Kit Carton)

An instructional illustration showing a hand holding a syringe with the thumb on the top, demonstrating the action of twisting or turning the syringe cap or plunger as indicated by an arrow. The drawing guides the user on the proper handling or assembly step for the syringe device.*

FDA Label Image

Principal Display Panel (250 IU Range Dual-Chamber Syringe Label)

An instructional illustration showing two hands each holding a syringe. The left syringe is shown with an upward arrow indicating a motion or action, while the right syringe is held steady. This diagram appears to demonstrate a step related to handling or preparing a syringe, likely for use with Xyntha (antihemophilic factor recombinant) kit.*

FDA Label Image

Principal Display Panel (Kit Carton)

An instructional diagram showing a hand opening a vial by removing a cap in the first step, and another hand holding a syringe connected to tubing likely used for drawing or administering medication. The illustration demonstrates part of the preparation or administration process for a medication kit.*

FDA Label Image

Principal Display Panel (500 IU Range Dual-Chamber Syringe Label)

An instructional line drawing showing the application of a small adhesive patch onto the forearm. The illustration highlights a hand holding the patch in place on the opposite arm.*

FDA Label Image

Principal Display Panel (Kit Carton)

An instructional diagram showing a hand holding a syringe connected by tubing to an injection site on the inner forearm near the elbow. This illustration likely demonstrates the intravenous administration technique for the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Principal Display Panel (2000 IU Range Dual-Chamber Syringe Label)

An instructional illustration showing a syringe being disposed into a medical sharps container marked with a biohazard symbol. This image demonstrates the proper disposal method for used syringes or needles.*

FDA Label Image

Principal Display Panel (Kit Carton)

An instructional illustration showing a pair of hands preparing a syringe. One hand is holding the syringe while the other hand is stabilizing a vial, indicating the syringe is about to be inserted into the vial, likely for drawing up medication.*

FDA Label Image

Principal Display Panel (3000 IU Range Dual-Chamber Syringe Label)

Instructional illustration showing two hands preparing a syringe. One hand holds the syringe barrel while the other hand is about to or has just removed the syringe cap. The image demonstrates the proper way to hold and handle the syringe before use.*

FDA Label Image

Principal Display Panel (Kit Carton)

Illustration showing a hand holding a syringe while inserting the needle into a vial, and another hand stabilizing the vial. The image depicts an instructional step likely related to preparing or drawing medication from the vial.*

FDA Label Image

Xyntha 32

An instructional illustration showing two hands performing a step in medication preparation: inserting a syringe into a vial. An arrow points downward to indicate the direction of syringe insertion into the vial.*

FDA Label Image

Xyntha 33

An instructional illustration showing hands preparing a medication kit. One hand holds a syringe being inserted or removed from a small vial, with an arrow indicating the motion. The image likely demonstrates a step in the preparation or mixing of the drug product Xyntha (antihemophilic factor recombinant) kit.*

FDA Label Image

Xyntha 34

An instructional black-and-white line drawing showing a person's hands assembling or using a medical device kit, possibly connecting a syringe to a vial, indicative of preparation steps for medication administration.*

FDA Label Image

Xyntha 35

An instructional illustration showing two hands holding a syringe and a vial. One hand holds the syringe upright while the other hand holds the vial, with an arrow indicating the syringe being inserted into the vial. This instructional image likely demonstrates proper preparation or mixing technique for the drug kit.*

FDA Label Image

Xyntha 36

Illustration showing a syringe being disposed of into a biohazard sharps container, indicating safe disposal of medical sharps.*

FDA Label Image

Xyntha 37

An instructional illustration showing hands holding a syringe, depicting the process of preparing or manipulating the syringe, possibly involving removing a cap or air before injection.*

FDA Label Image

Xyntha 38

An instructional diagram showing two hands connecting a syringe to another device by aligning and twisting components indicated by arrows. It demonstrates the assembly process involved in preparing the medication device or kit.*

FDA Label Image

Xyntha 39

An instructional illustration showing a hand using a syringe, with an arrow indicating the direction to pull or push the plunger. The diagram likely depicts a step in preparing or administering medication using the syringe.*

FDA Label Image

Xyntha 40

An instructional line drawing showing a syringe being disposed into a biohazard sharps container. This illustration relates to safe disposal of medical sharps, commonly found in pharmaceutical kit instructions.*

FDA Label Image

Xyntha 41

FDA Label Image

Xyntha 42

Xyntha Solofuse Kit label for antihemophilic factor (recombinant) in a dual-chamber syringe for IV administration. The label indicates 1000 IU strength for Factor VIII replacement, manufactured by Wyeth Pharmaceuticals LLC. The top chamber contains freeze-dried antihemophilic factor, and the bottom chamber contains 0.9% sodium chloride diluent, 4 mL, preservative-free.*

FDA Label Image

Xyntha 43

Packaging label for Xyntha Solofuse antihemophilic factor (recombinant) kit containing a prefilled dual-chamber syringe. The label states 1000 IU strength, intended for intravenous administration and Factor VIII replacement therapy only. The product is manufactured by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary.*

FDA Label Image

Xyntha 44

Xyntha Solofuse 250 IU dual-chamber syringe kit containing antihemophilic factor (recombinant) for IV administration. The label indicates a dual-chamber syringe with a top chamber holding sterile, nonpyrogenic, preservative-free freeze-dried powder, and a bottom chamber containing 4 mL of 0.9% sodium chloride diluent without preservatives. The product is by Wyeth Pharmaceuticals LLC.*

FDA Label Image

Xyntha 45

Packaging label for Xyntha solofuse, antihemophilic factor (recombinant) 250 IU kit. It is a single-use, dual-chamber prefilled syringe for intravenous administration, containing Xyntha and diluent. The label notes it is for Factor VIII replacement therapy only and manufactured by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary.*

FDA Label Image

Xyntha 46

Xyntha Solofuse kit label featuring a dual-chamber syringe containing antihemophilic factor (recombinant) for Factor VIII replacement. The label indicates 500 IU strength, designed for IV administration without preservatives. It includes storage instructions to refrigerate and protect from light. The product is manufactured by Wyeth Pharmaceuticals LLC, Philadelphia, PA.*

FDA Label Image

Xyntha 47

Packaging label for Xyntha solofuse 500 IU, a single-use, prefilled dual-chamber syringe kit containing antihemophilic factor (recombinant) for Factor VIII replacement therapy. The label indicates intravenous administration and details components of the kit. It is manufactured by Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, a Pfizer subsidiary.*

FDA Label Image

Xyntha 48

Packaging label for Xyntha Solofuse Dual-Chamber Syringe containing antihemophilic factor (recombinant) 2000 IU. The kit is for IV administration and contains a sterile, nonpyrogenic, preservative-free freeze-dried powder in the top chamber and 0.9% sodium chloride diluent in the bottom chamber. Manufactured by Wyeth Pharmaceuticals LLC.*

FDA Label Image

Xyntha 49

Packaging label for Xyntha Solofuse 2000 IU, a kit containing antihemophilic factor (recombinant) for intravenous administration. The label indicates a single-use, prefilled dual-chamber syringe with the product and diluent. It is manufactured by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label highlights the product is for Factor VIII replacement therapy only and includes details such as storage instructions and country of manufacture for various components.*

FDA Label Image

Xyntha 50

Packaging label for Xyntha Solofuse dual-chamber syringe kit containing antihemophilic factor (recombinant) indicated for Factor VIII replacement. The label shows the product name, strength of 3000 IU, and instructions to refrigerate and protect from light. It is labeled for IV administration, preservative-free, and marked for prescription use only. The manufacturer is Wyeth Pharmaceuticals LLC, Philadelphia, PA.*

FDA Label Image

Xyntha 51

Packaging label for Xyntha Solofuse, antihemophilic factor (recombinant) kit, containing a single-use, prefilled dual-chamber syringe with 3000 IU range dosage. The label indicates it is for Factor VIII replacement therapy only and for intravenous administration. Manufactured by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The kit includes the syringe prefilled with XYNTHA and diluent, along with injection supplies and instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.